{
    "2018-05-07": [
        [
            {
                "time": "",
                "original_text": "[买入评级] 上海医药(601607)公告点评：收入增长9.8% 工业板块表现突出",
                "features": {
                    "keywords": [
                        "上海医药",
                        "收入增长",
                        "工业板块"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[增持评级] 医药生物行业周报：行业分化、集中度提升明显 紧握高景气龙头",
                "features": {
                    "keywords": [
                        "医药生物",
                        "行业分化",
                        "集中度提升",
                        "高景气龙头"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业：全行业景气度回升 继续推荐优质成长股",
                "features": {
                    "keywords": [
                        "医药生物",
                        "景气度回升",
                        "优质成长股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[买入评级] 上海医药(601607)季报点评：主业稳健增长 整合发挥集团优势",
                "features": {
                    "keywords": [
                        "上海医药",
                        "主业稳健增长",
                        "整合",
                        "集团优势"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[谨慎推荐评级] 上海医药(601607)一季报点评：利润增速受参股企业拖累 公司工、商业业绩超预期",
                "features": {
                    "keywords": [
                        "上海医药",
                        "利润增速",
                        "参股企业拖累",
                        "工商业业绩超预期"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "[买入评级] 上海医药(601607)一季报点评：医药工业快速增长 医药商业盈利能力进一步提升",
                "features": {
                    "keywords": [
                        "上海医药",
                        "医药工业",
                        "快速增长",
                        "医药商业",
                        "盈利能力提升"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "申万宏源：医药生物全行业景气度回升",
                "features": {
                    "keywords": [
                        "申万宏源",
                        "医药生物",
                        "景气度回升"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}